NHF in Acute Hypercapnic Acute Exacerbation of COPD

Jens Bräunlich, MD38 enrolled

Overview

Patients with AECOPD and NIV failure and in absence will be treated with NHF device. Inclusion criteria are pH \< 7,38 and pCO2 \> 45 mm Hg. Patients were treated if pH \>7,38 or refusal of therapy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Safety of NHF in Acute Hypercapnic AECOPD

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * pH \< 7,38 * hypercapnic AECOPD Exclusion Criteria: * Need of intubation

Locations (1)

University of Leipzig

Leipzig, Germany

Outcomes

Primary Outcomes

Increase in pH

Time frame: up to 24 hours

Secondary Outcomes

pCO2

Decrease in pCO2

Time frame: up to 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.